The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates.
Ye G, Gallant J, Zheng J, Massey C, Shi K, Tai W, Odle A, Vickers M, Shang J, Wan Y, Du L, Aihara H, Perlman S, LeBeau A, Li F.
Ye G, et al. Among authors: shang j.
Elife. 2021 Aug 2;10:e64815. doi: 10.7554/eLife.64815.
Elife. 2021.
PMID: 34338634
Free PMC article.